U.S. Legal Cannabis Market to Grow to $24.1 Billion by 2025

Based on these revised projections, the legal cannabis market was worth an estimated $6.6 billion in 2016, and is projected to grow at a compound annual growth rate (CAGR) of 16% to reach more than $24 billion by 2025. The medical market is projected to grow at 12% CAGR through 2025, growing from $4.7 billion in 2016 to an estimated $13.3 billion in 2025. During the same period, adult use sales are projected to grow at a 21% CAGR, from $1.9 billion to $10.9 billion (through projections based solely on the markets having passed medical and adult use legalization initiatives as of January 2017, but not including assumptions for additional states which may yet pass legalization measures before 2025).

DISTRICT OF COLUMBIA: New Frontier Data, a leading cannabis industry business intelligence firm, has refined its market projections for adult use and medical markets across the country,  according to The Cannabis Industry Annual Report: 2017 Legal Marijuana Outlook. The firm forecast the legal cannabis market to grow to $24.1 billion by 2025 with a compound annual growth Read the full article…

Massachusetts Marijuana Sales to Top $1 Billion by 2020

$1 Billion in mj sales predicted for Mass by 2020

MASSACHUSETTS: Arcview Market Research, in partnership with New Frontier Data, has released its Massachusetts Legal Cannabis Market State Profile, which shows the potential growth of the legal marijuana market after Massachusetts voters legalized adult-use on Election Night 2016. The official Arcview Market Research projection for the Massachusetts market is that it will grow to over $1 Read the full article…

2016 Cannabis Investment Study: 68% Of Investors Open to Businesses That Touch Marijuana

2016 CANNABIS INVESTOR STUDY

DISTRICT OF COLUMBIA: New Frontier Data, in partnership with Arcview Market Research and The Arcview Investor Network has released its 2016 Cannabis Investment Study. The study unveils insights from Arcview’s members and shows that despite the differences in regulations affecting businesses that touch cannabis and ancillary businesses that do not touch cannabis, the majority of investors (68%) are now Read the full article…